Xenopus oocytes from unprimed frogs possess insulin-like growth factor I (IGF-I) receptors but lack insulin and IGF-I receptor substrate 1 (IRS-1), the endogenous substrate of proteins expressing the SH2 domains of ras-GAP or phospholipase C-y. Moreover, inijection of the SH2 domains of p85, ras-GAP, and phospholipase C-y do not interfere with progesterone-induced oocyte maturation. These data demonstrate that phosphorylation of IRS-1 plays an essential role in IGF-I and insulin signaling in oocyte maturation and that this effect occurs through interactions of the phosphorylated YMXM/YXXM motifs of IRS-1 with SH2 domains of Ptdlns 3-kinase or some related molecules.
Insulin, insulin-like growth factor I (IGF-I), and other polypeptide growth factors regulate a wide range of cellular functions through the activation of membrane receptors with tyrosine kinase activity (8, 13, 28, 49, 61, 63) . Mutations in the ATP-binding site (9, 16) and autophosphorylation sites (18, 65) in the 3-subunit of the insulin receptor inhibit insulin receptor kinase activity and biological responses. Over the past few years, several of the proteins and enzymes involved in linking the insulin receptor to its final effects have been elucidated. Two of the earliest in the pathway are the insulin and IGF-I receptor substrate 1 (IRS-1) (26, 29, 40, 50, 60, 64) and the enzyme phosphatidylinositol (PtdIns) 3-kinase (8, 19, 51) .
IRS-1 is a high-molecular-weight cytosolic protein which possesses over 10 potential tyrosine phosphorylation sites (60) . Following insulin-and IGF-I-stimulated phosphorylation, IRS-1 rapidly associates with and activates the cytosolic enzyme PtdIns 3-kinase (2, 3, 22, 60) . The interaction between PtdIns 3-kinase and IRS-1 is directed through the highly conserved phosphopeptide sequence motifs (YMXM/ YXXM) of IRS-1 and the src homology 2 (SH2) domain of the 85-kDa subunit of PtdIns 3-kinase (2, 39, 46, 53) . SH2 domains are conserved regions that form specific binding sites for phosphotyrosine residues in certain amino acid sequence motifs (reviewed in reference 30). The p85 regulatory subunit of Ptdlns 3-kinase contains two SH2 domains and one SH3 domain (20, 42, 55) . PtdIns 3-kinase binds to specific tyrosine phosphorylation motifs in IRS-1 and various growth factor receptors via these SH2 domains (reviewed in reference 8). Other SH2 domain-containing proteins, such as pp60v-"c, phospholipase Cy (PLC-y) and the ras-associated GTPase-activating protein (ras-GAP), bind to the epidermal growth factor, platelet-derived growth factor, and colony-stimulating factor 1 receptors and the polyoma middle T antigen at similar, but not identical, sequence motifs (reviewed in references 8, 21, 25, 30, 36, and 43) . Little is known about the function of interactions through these SH2-containing proteins in the insulin signaling pathway.
Xenopus oocytes taken from unprimed frogs possess IGF-I receptors but lack IRS-1 and have little or no response to insulin or IGF-I. Recently, we demonstrated a critical functional role for IRS-1 in insulin-and IGF-I-induced oocyte maturation by microinjecting recombinant IRS-1 protein and reconstituting the germinal vesicle breakdown response (10) . To examine the exact molecular interactions required downstream of IRS-1, in the present study, we have used this reconstitution system to evaluate the role of PtdIns 3-kinase and the interaction of IRS-1-containing YMXM/ YXXM motifs and the SH2 domain of p85 of PtdIns 3-kinase.
MATERIALS AND METHODS
Oocyte preparation and microinjection. Stage VI oocytes were isolated by mild collagenase treatment of ovaries from 6653 gravid Xenopus laevis frogs (Nasco, Fort Atkinson, Wis.) without previous priming with gonadotropin (6) . The oocytes were allowed to recover overnight in modified Barth's media and were then microinjected with 50 nl of either buffer (125 mM NaCl, 25 mM Tris-HCl [pH 7.6]) alone or combinations of peptides and proteins at appropriate concentrations as indicated.
Recombinant rat liver IRS-1 was produced in a baculovirus expression system and purified to >90% homogeneity as previously described (39) . Glutathione S-transferase (GST) fusion proteins were produced from bacterial expression vectors (pGEX) containing the SH2 domains of p85 (N terminal, designated GST-nSH2p85), ras-GAP (N terminal, GST-nSH2rasTG`-), and PLC-y (N terminal, GST-nSH2PLCY) as GST fusion constructs (30) . Bacterial lysates were purified on a glutathione-Sepharose column (Pharmacia) as previously described (56) . The proteins were then dialyzed extensively against a degassed buffer of 88 mM NaCl and 50 mM Tris-HCl, pH 8.0, aliquoted, and stored at -80°C until use.
Phosphonomethylalanine (Pmp), a nonnatural analog of phosphotyrosine, was used to synthesize a nonhydrolyzable phosphonopeptide of the region containing YMXM of the mouse polyomavirus middle T antigen [EEE (PmP) MPMEDLY] (15) . This peptide was >90% pure on the basis of high-pressure liquid chromatography (HPLC) analysis in reverse-phase C-18 columns.
PtdIns 3-kinase assay. PtdIns 3-kinase activity was measured by in vitro phosphorylation of PtdIns as previously described (51) with minor modifications. After microinjection with either peptide or protein combinations, oocytes were treated with insulin or IGF-I at the indicated concentrations at 19°C for 5 min (except as otherwise indicated). The incubation medium was removed, and oocytes were extracted with a lysis buffer containing 50 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; pH 7.4), 137 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, 2 mM Na3VO4, 10 mM Na PPi, 10 mM NaF, 2 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 10 mM benzamidine, 10 ,ug (each) of aprotinin and leupeptin per ml, 10% glycerol, and 1% Nonidet P-40. Undissolved material was removed by centrifugation at 12,000 x g for 5 min. PtdIns 3-kinase activity was then assayed in the immunoprecipitates with either anti-IRS-1 or anti-p85 antibodies which were collected on protein A-Sepharose (Pharmacia). These antibodies were produced as previously described (2, 39 (6) . After microinjection with IRS-1 and/or GST-SH2 fusion proteins, oocytes were incubated for 3 h and then transferred to the media containing insulin at 10 ,uM. After a 20-h incubation, groups of 15 to 20 oocytes were scored for germinal vesicle breakdown (GVBD) by the appearance of a white spot on the animal pole of the oocyte. In some experiments, this was confirmed by the microscopic absence of nuclear membrane after oocytes were fixed in 5% trichloroacetic acid for 30 min.
MAP kinase activity assay. Groups of oocytes were lysed in a buffer containing 50 mM ,-glycerophosphate (pH 7.4), 5 mM MgCl2, 5 mM ethylene glycol-bis(,B-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 1 mM benzamidine, 0.5 mM Na3VO4, 0.1 mM phenylmethylsulfonyl fluoride, 10 ,ug of leupeptin per ml, and 1 mM dithiothreitol. Crude cell extracts were aliquoted and stored at -80°C after centrifugation at 13,000 x g for 10 min at 4°C. Kinase reaction was performed in the cell lysate (equivalent to 1. Reactions were terminated after 15 min at 30°C by adding a 1/2 volume of 2 M HCl. Samples (25 ,ul) were spotted onto p81 phosphocellulose paper disks (GIBCO) and washed twice in 1% acetic acid and twice in H20. The disks were then dried and counted for radioactivity (Cerenkov method).
Nonspecific 32p incorporation was determined in identical assays lacking cell lysates. Each measurement was done in duplicate in at least two experiments.
RESULTS

Microinjection of IRS-1 enhances insulin-stimulated PtdIns
3-kinase activation in Xenopus oocytes. Xenopus oocytes prepared from frogs which have not received gonadotropin treatment possess endogenous IGF-I receptors but have little or no detectable IRS-1 (10, 24, 27, 38) . In these oocytes, insulin and IGF-I stimulated only a small increase in PtdIns 3-kinase activity as assayed in immunoprecipitates with either anti-IRS-1 ( Fig. 1 ) or anti-p85 (Fig. 2) antibodies. This activation was maximal after 5 min of insulin stimulation, a relatively slow time course compared with that in mammalian cells (data not shown). Following injection of baculovirus-produced IRS-1 protein (12.5 ng per oocyte), insulin stimulated a fourfold-greater increase in both IRS-1-associated and total PtdIns 3-kinase activities ( Fig. 1B and 2 ). Both insulin and IGF-I stimulated the association of PtdIns 3-kinase with IRS-1 in a concentration-dependent manner, with IGF-I being 100-fold-more potent than insulin, consistent with stimulation via an IGF-I type receptor (Fig. 1B) .
The 85-kDa subunit of the endogenous PtdIns 3-kinase in Xenopus oocytes could be detected by immunoblotting of immunoprecipitates prepared with 50 to 100 oocytes by using antibodies raised to the mammalian enzyme (Fig. 3 , lane j). Association of IRS-1 and p85 of PtdIns 3-kinase, as assessed by coprecipitation of the two proteins with anti-IRS-1, followed a pattern consistent with the enzymatic activity data. In the absence of injected IRS-1, no p85 was observed in anti-IRS-1 precipitates in either the absence or presence of insulin stimulation (Fig. 3, lanes a and b) . Following sented about 10% the total PtdIns 3-kinase in the oocyte (Fig. 3, compare lanes d and h) . When normalized for the amount of the p85 protein brought down by these antibodies, the specific activity of IRS-1-associated Ptdlns 3-kinase after IRS-1 microinjection and insulin stimulation was significantly higher than that in the total pool of PtdIns 3-kinase (17-fold increase in IRS-i-associated Ptdlns 3-kinase specific activity compared with a 2.7-fold increase in p85-associated
PtdIns 3-kinase specific activity in anti-p85 immunoprecipitates). There was no evidence of tyrosine phosphorylation of p85 on the basis of immunoprecipitation by antiphosphotyrosine antibodies followed by blotting with anti-p85 antibody (Fig. 3, lane i) . These findings are consistent with activation of PtdIns 3-kinase by binding to the phosphorylated IRS-1 following insulin stimulation (2, 22, 53 tested the ability of a GST fusion protein containing the N-terminal SH2 domain of the p85 (GST-nSH2p85) to inhibit the association between IRS-1 and PtdIns 3-kinase in the oocytes. As noted above, following injection of IRS-1 into the oocytes and insulin stimulation, immunoprecipitation with anti-IRS-1 antibody resulted in coprecipitation of the p85 subunit of PtdIns 3-kinase with IRS-1 molecules, suggesting that p85 and IRS-1 form a stable complex during insulin stimulation (Fig. 4, second lane from left) . Formation of this complex was blocked by comicroinjection of GSTnSH2p85 (Fig. 4, far right lane) . Furthermore, the presence of a large amount of GST-SH2 protein in the anti-IRS-1 immunoprecipitates indicates that the GST-SH2 protein bound to the phosphorylated YMXM sites in IRS-1, preventing the binding of the PtdIns 3-kinase. As a result, both the binding of PtdIns 3-kinase to IRS-1 and its activation upon insulin stimulation were inhibited by GST-nSH2p85 when assayed in either the anti-IRS-1 (Fig. SA) or the anti-p85 (Fig. SB) immunoprecipitates. This effect occurred in a concentrationdependent fashion, and blockade was almost complete when the GST-SH2 protein was injected in a three-to fourfold molar excess over the IRS-1.
As previously observed (10), IRS-1 microinjection enhances insulin and IGF-I induction of oocyte maturation in the oocytes isolated from the frogs without gonadotropin priming, and in these oocytes, insulin-induced oocyte maturation was blocked by coinjection of GST-nSH2 of p85 (Fig.  6, bottom panel) . The activation of MAP kinase in the oocytes with IRS-1 and insulin treatment was also blocked by GST-nSH2 of p85 ( Table 1 ). The decrease in the insulin stimulation of GVBD correlated well with the degree of inhibition of PtdIns 3-kinase activity by GST-nSH2P85 (Fig.   6 , compare all panels). This effect was specific, as microinjection of equivalent amounts of GST-nSH2ras-GAP or GSTnSH2PLCY did not inhibit the insulin-stimulated PtdIns 3- kinase activation and oocyte maturation responses (Fig. 7) (Fig. 8A, lanes e and f) . To rule out the possibility that inhibition of oocyte maturation by GST-nSH2P85 was due to decreased stability and/or decreased tyrosine phosphorylation of IRS-1, we studied the effect of GST-nSH2P85 on IRS-1 stability and phosphorylation. Microinjection of increasing amounts of GST-nSH2P85 appears to actually enhance both the stability and tyrosine phosphorylation of injected IRS-1 after insulin stimulation (Fig. 8) . This suggests that the binding of GST-nSH2P protein protects phosphorylated IRS-1 from the actions of some proteases and/or phosphotyrosine phosphatases present in the oocyte.
IRS-1 binds p85 of Ptdlns 3-kinase through phosphorylated YMXM/YXXM motifs. Previous work has suggested that IRS-1 interacts with the SH2 domains of PtdIns 3-kinase via the repetitive tyrosine-phosphorylated YMXM and YXXM motifs (2, 39, 46, 60, 66) . To test this possibility directly, phosphorylated and unphosphorylated peptides containing YMXM motifs from IRS-1 or related proteins were microinjected into Xenopus oocytes. However, these peptides were rapidly degraded by endogenous proteases and/or phosphatases and appeared to have no effect on IRS-1 association of PtdIns 3-kinase (data not shown). Therefore, we prepared a phosphonopeptide containing a YMXM motif known to have high affinity for the p85 of PtdIns 3-kinase by using the nonhydrolyzable phosphotyrosine analog Pmp. The half-life of this peptide after microinjection into the oocytes was about 1 h as shown by the HPLC analysis of the iodinated peptide (data not shown). Furthermore, the presence of the phosphonopeptide blocked insulin-stimulated PtdIns 3-kinase activation for 1 and 2 h after microinjection (Fig. 9) . These data support the notion that the phosphorylated YMXM/YXXM motifs in IRS-1 are the major site of binding to the p85 of Ptdlns 3-kinase. 
DISCUSSION
Xenopus oocytes provide a unique system for reconstitution of the insulin and IGF-I action cascade. Previous studies have shown that Xenopus oocytes possess many of the serine/threonine kinases involved in the insulin action cascade (7, 33, 35, 44, 58) and possess IGF-I receptors (24, 27, 34) ; however, presence of the novel PtdIns 3-kinase has not been reported. In this study, we demonstrated that PtdIns 3-kinase exists in Xenopus oocytes and can be activated by insulin and IGF-I via the IRS-1 protein. Furthermore, IRS-1 associates with Ptdlns 3-kinase through an interaction between YMXM/YXXM sequence motifs and SH2 domains, and inhibition of this association selectively blocks not only insulin-stimulated PtdIns 3-kinase activation but also oocyte maturation.
Over the past decade, considerable evidence has indicated that insulin and IGF-I exert their functions through the binding and activation of their receptor tyrosine kinases. By using antiphosphotyrosine antibodies, several proteins have been implicated as potential substrates for the kinases, including ppl85/IRS-l (26, 29, 64) , pp120 (37, 45) , pp46 (25) , and pp15 (5) . Recently, we purified and cloned IRS-1 from rat liver and human muscle at the cDNA level and from mice, rats, and humans at the genomic level (1, 50, 60) . On the basis of the deduced sequence, IRS-1 is a unique signaling molecule with multiple tyrosine phosphorylation sites in YMXM or YXXM motifs which act as docking sites for SH2 domain proteins, particularly the SH2 of the 85-kDa subunit of the PtdIns 3-kinase. All of the potential tyrosine phosphorylation sites and >90% of the remainder of the protein sequence are conserved among the three species studied (1, 41) . Expression of IRS-1 in CHO cells enhances insulin stimulation of thymidine incorporation, suggesting a role for IRS-1 in insulin-stimulated mitogenic responses (59) .
Xenopus oocytes possess IGF-I receptors and, under some circumstances, respond to insulin or IGF-I with a modest stimulation of the maturation response (4, 11, 17, 23, 24, 31, 32, 34, 62) . Insulin and IGF-I signalings in these oocytes involve tyrosine phosphorylation and can be blocked by microinjection of antiphosphotyrosine antibody or phosphotyrosine phosphatases (12, 23) . Several phosphotyrosyl proteins have been implicated in these signaling events, including the IGF-I receptor, the MPF component p34cdc2, MAP kinases, and the Xenopus homolog of pp6O"S' (12, 33) . Although a 160-kDa phosphotyrosine protein has been reported in the microsomal fraction of the Xenopus oocyte (12) , in oocytes isolated from the frogs without gonadotropin priming, we find little or no IRS-1 upon immunoblotting with any of three anti-IRS-1 antibodies (anti-C terminal, anti-N terminal, or anti-pep80) or with antiphosphotyrosine antibodies (10) . Likewise, in the present study, we find little or no IRS-1-associated PtdIns 3-kinase activation in unprimed oocytes. Of course, we cannot rule out the possibility that our antibodies do not cross-react with frog IRS-1 or that the protein is of low abundance and undetectable by these means.
Following microinjection of recombinant IRS-1, there is a rapid insulin and IGF-I stimulation of PtdIns 3-kinase which parallels receptor autophosphorylation and tyrosine phos- The interaction between IRS-1 and the Ptdlns 3-kinase is mediated via the SH2 domains of the p85 of Ptdlns 3-kinase. Thus, insulin-stimulated PtdIns 3-kinase activity and the GVBD response are blocked by GST-containing the N-terminal SH2 domain of p85 but not by the GST-SH2 of ras-GAP and PLCy. Microinjected GST-nSH2P85 also blocks the association of phosphorylated IRS-1 with p85. This inhibitory action of the GST fusion protein is not due to an effect on the stability or tyrosine phosphorylation of IRS-1. Indeed, the stability and tyrosine phosphorylation of the IRS-1 are actually enhanced following injection of the GST-SH2 85. Furthermore, IRS-1 and/or GST-SH2 microinjection had no effect on the ability of progesterone to stimulate oocyte maturation, and progesterone had no effect on PtdIns 3-kinase activity.
The interaction of IRS-1 and p85 subunit of PtdIns 3-kinase is also mediated through the YMXM/YXXM sequence motifs of the IRS-1 protein. Phosphopeptides containing such motifs bind to the p85 and lead to a conformational change and activation of PtdIns 3-kinase in vitro (2, 39, 46, 53) . The data of the present study show that this interaction also occurs inside the oocytes. Peptides containing YMXM sequences with a nonhydrolyzable derivative of phosphotyrosine inhibit the IRS-1 association with and activation of the PtdIns 3-kinase which follows insulin stimulation. However, the effect of the injected peptide is only transient in the oocyte because of peptide degradation. Thus, the transmission of specific insulin signals depends on interaction of IRS-1 with SH2-containing signaling molecules and is blocked by inhibiting the binding of this class of molecules to IRS-1.
Both progesterone and insulin can induce oocyte maturation through separate, but converging, signaling pathways (33, 57 
